Healthcare
Small-cap - With a market cap of ₹15.53 Cr.
| EX-Date | Purpose |
|---|---|
| 05 05 2021 | Audited Results |
| 09 08 2021 | Quarterly Results |
| 26 10 2021 | Quarterly Results |
| 02 02 2022 | Quarterly Results |
| 25 05 2022 | Final Dividend & Audited Results |
| 26 07 2022 | Quarterly Results |
| 18 10 2022 | Quarterly Results |
| 17 01 2023 | Quarterly Results |
| 15 05 2023 | Audited Results & Final Dividend |
| 18 05 2023 | Final Dividend (Revised) & Audited Results |
| 20 07 2023 | Quarterly Results |
| 27 10 2023 | Quarterly Results |
| 07 02 2024 | Quarterly Results |
| 30 10 2024 | Quarterly Results |
| 03 02 2025 | Quarterly Results |
| 29 05 2025 | Quarterly Results & Final Dividend & Audited Results |
| 13 08 2025 | Quarterly Results |
| 13 11 2025 | Quarterly Results |
| 11 02 2026 | Quarterly Results |
With the launch of these advanced services, the hospital is now equipped to provide integrated cancer care
This collaboration aims to provide B.Voc in Medical Laboratory Technology, B.Voc. in Operation Theatre & Anesthesia Technology and B.Voc. in Medical Radiology Imaging Technology
This collaboration aims to launch undergraduate and postgraduate programs in Healthcare and Hospital Management
With this new venture, the company will be able to distribute bone grafts to hospitals, surgeons, and even direct-to-patient on a prescription basis
Based on the safety and effectiveness data, USFDA has determined the device is substantially equivalent to legally marketed predicate devices
Shalby Advanced Technologies, Inc., USA has incorporated its Wholly-Owned Subsidiary under the name and style of ‘Shalby Advanced Technologies India’
The company is all set to acquire 100% equity stake in Healers Hospital for a consideration of around Rs 104 crore
This equity stake will be acquired within a period of one month, through secondary buy-outs
With this acquisition, Sanar International hospitals will be able take advantage of Shalby’s global presence and leadership in Orthopaedics
This MoU signifies the company’s commitment to collaboratively organize diverse healthcare skill enhancement initiatives in the upcoming years
The Board of Directors of company’s Wholly-owned Subsidiary, at its meeting held on December 18, 2023 has approved the same
The Management Committee of Directors at its meeting held on December 12, 2023 has approved the same
The Company will construct 175 beded new hospital at Santacruz, Mumbai
The said hospital at Ranchi under Franchise-Owned Shalby-Managed, is now operationalized from August 6, 2023
Total consolidated income of the company increased by 16.70% at Rs 240.02 crore for Q1FY24
This collaboration further enhances Shalby’s commitment to collaborate with various universities across India
This collaboration aligns with its long-term vision of expanding company’s presence and making quality healthcare accessible to a wider population
This collaboration further enhances Shalby’s commitment to collaborate with various universities across India
Total consolidated income of the company increased by 24.77% at Rs 208.16 crore for Q4FY23
The objective of acquisition is to manufacture, trade, import and export the Medical Devices/ equipment
With the aforesaid investment, shareholding of MMDL in SGTPL is now increased to 99.33% from earlier 99.16%
The company has signed MoU to jointly develop various vocational undergraduate & post Graduate courses in allied health science
This will be a customized program for healthcare professionals aspiring to become CXOs in the Hospital Industry
Now, SGT can import the said implants and medical devices from USA and sell in Indonesia
The board of directors at its meeting held on February 06, 2023 has approved the same
SOCE Gwalior is a state- of-the-art orthopedic centre that will provide comprehensive orthopedic services under one roof
Total consolidated income of the company increased by 25.01% to Rs 206.50 crore for Q3FY23
With the aforesaid investment, shareholding of MMDL in SGTPL is now increased to 99.16% from earlier 98.99%
SGTPL is a subsidiary of Mars Medical Devices and a step-down subsidiary of the company





